Sirtuin 1 inhibitor EX527 suppresses morphine-induced behavioral sensitization

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Morphine addiction is a chronic brain disease with severe consequences.
• Sirtuin 1 (SIRT1) is implicated in learning, memory, and reward pathways.
• The role of SIRT1 in morphine addiction remains largely uncharacterized.

Purpose of the Study:

• To investigate the association between SIRT1 in the ventrolateral orbital cortex (VLO) and morphine addiction.
• To explore the underlying molecular mechanisms involving SIRT1 in morphine addiction.

Main Methods:

• Utilized the morphine-induced behavioral sensitization paradigm in rats.
• Administered EX527, a SIRT1 inhibitor, via microinjection into the VLO.
• Assessed the expression of SIRT1, phosphorylated ERK (p-ERK), and BDNF in the VLO.

Main Results:

• Microinjection of EX527 into the VLO significantly reduced morphine-induced behavioral sensitization.
• Morphine administration increased the expression of SIRT1, p-ERK, and BDNF in the VLO.
• EX527 treatment inhibited these morphine-induced increases in VLO expression.

Conclusions:

• SIRT1 in the VLO plays a critical role in mediating morphine-induced behavioral sensitization.
• Overexpression of SIRT1, p-ERK, and BDNF in the VLO is a potential mechanism underlying morphine addiction.
• Targeting SIRT1 in the VLO with inhibitors like EX527 may offer a therapeutic strategy for morphine addiction.